Chemed Corp. (CHE) Misses Q3 EPS by 7c; Guides FY12 EPS Below Consensus
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $504.06 -0.38%
Revenue Growth %: +7.9%
Financial Fact:
Income from operations: 42.87M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +7.9%
Financial Fact:
Income from operations: 42.87M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Chemed Corp. (NYSE: CHE) reported Q3 EPS of $1.28, $0.07 worse than the analyst estimate of $1.35. Revenue for the quarter came in at $354 million versus the consensus estimate of $360.5 million.
Chemed Corp. sees FY2012 EPS of $5.20-5.30, versus the consensus of $5.37.
For earnings history and earnings-related data on Chemed Corp. (CHE) click here.
Chemed Corp. sees FY2012 EPS of $5.20-5.30, versus the consensus of $5.37.
For earnings history and earnings-related data on Chemed Corp. (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Investing.com’s stocks of the week
- Arrive AI and DXC Technology partner to bring delivery tech to factories
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
